首页> 美国卫生研究院文献>JBMR Plus >Is There Proof of Extraskeletal Benefits From Vitamin D Supplementation From Recent Mega Trials of Vitamin D?
【2h】

Is There Proof of Extraskeletal Benefits From Vitamin D Supplementation From Recent Mega Trials of Vitamin D?

机译:来自维生素D的维生素D的Qualeta益智源的证据吗?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Scientific interest in possible extraskeletal effects of vitamin D first appeared in the 1930s soon after the structure of vitamin D was characterized, and increased in the 1980s with the development of assays of 25‐hydroxyvitamin D status as a marker of vitamin D status, which in observational epidemiological studies was shown to be inversely associated with many nonskeletal diseases. This resulted in the start of seven large randomized controlled trials (n > 2000 participants in each) of vitamin D supplementation giving higher doses than previously used. The intervention periods in these trials collectively started in 2009 and continued to 2020. They have recruited participants, mostly of both sexes and over the age of 50 years, from many countries and have given either daily or monthly doses of vitamin D. Collectively, the trials have a wide range of outcomes with the main focus on the prevention of cancer, cardiovascular disease, and fractures, besides many other outcomes. The findings of four trials have been published, and they have shown that vitamin D supplementation does not prevent hard‐disease endpoints, such as cardiovascular disease, cancer, fractures, or falls, aside from a possible beneficial effect against cancer mortality. In contrast, beneficial effects were seen for intermediate outcomes such as BMD of spine and hips, arterial function, and lung function, especially in people with vitamin D deficiency. The finding of a benefit primarily in people with vitamin D deficiency, if confirmed by the other trials, would support a population approach to preventing vitamin D deficiency using fortification rather than the high‐risk approach of screening for deficiency combined with supplementation. The findings on other outcomes from the three published trials, along with the findings from the four unpublished trials, are expected within the next 2 to 3 years to clarify the role of vitamin D supplementation in preventing nonskeletal disease. © 2020 The Authors. JBMR Plus published by Wiley Periodicals LLC. on behalf of American Society for Bone and Mineral Research.
机译:维生素D的可能颗粒率的科学兴趣首先出现在20世纪30年代的维生素D结构后,在20世纪80年代越来越多,随着25-羟基维生素D质量的测定为维生素D状态的标记,在观察性流行病学研究显示与许多内骨骼疾病相反。这导致了七种大型随机对照试验(N> 2000人参与者)的维生素D补充剂的开始,其含量高于以前使用的剂量。这些试验中的干预期统称于2009年,并持续到2020年。他们招募了参与者,大多数是50岁以来,来自许多国家,并给予每日或每月剂量的维生素D.除了许多其他结果之外,试验具有各种结果,主要关注预防癌症,心血管疾病和骨折。已经公布了四次试验的结果,他们表明维生素D补充不会阻止硬疾病终点,例如心血管疾病,癌症,骨折或跌倒,除了可能的抗癌死亡率。相比之下,对于脊柱和臀部,动脉函数和肺功能的BMD等中间结果观察有益效果,特别是在维生素D缺乏的人们中。如果通过其他试验证实,患有维生素D缺乏症的人的福利将支持使用强化的人口方法,而不是使用缺陷的筛选的高风险方法来预防维生素D缺乏症。来自三项公布试验的其他结果的调查结果以及四项未发表试验的调查结果预计将在未来2至3年内预计澄清维生素D补充在预防内骨骼疾病方面的作用。 ©2020作者。 JBMR Plus由Wiley期刊LLC发布。代表美国人骨骼和矿物学研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号